BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1423251)

  • 1. Knowledge of colorectal cancer among older persons.
    Weinrich SP; Weinrich MC; Boyd MD; Johnson E; Frank-Stromborg M
    Cancer Nurs; 1992 Oct; 15(5):322-30. PubMed ID: 1423251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts].
    Loss J; Eichhorn C; Nagel E
    Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of older adults' participation in fecal occult blood screening.
    Weinrich SP
    Oncol Nurs Forum; 1990; 17(5):715-20. PubMed ID: 2251189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults.
    Berkowitz Z; Hawkins NA; Peipins LA; White MC; Nadel MR
    J Am Geriatr Soc; 2008 Feb; 56(2):307-14. PubMed ID: 18070002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving colorectal cancer screening in a medical residents' primary care clinic.
    Struewing JP; Pape DM; Snow DA
    Am J Prev Med; 1991; 7(2):75-81. PubMed ID: 1910891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Meissner HI; Breen N; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test-- identification of higher priority subjects in health education.
    Wei N; Nakama H; Li T
    Eur J Med Res; 1998 Jul; 3(7):341-4. PubMed ID: 9682030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
    Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
    Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication and colorectal cancer screening among the uninsured: data from the Health Information National Trends Survey (United States).
    Cairns CP; Viswanath K
    Cancer Causes Control; 2006 Nov; 17(9):1115-25. PubMed ID: 17006717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal occult blood testing: comparative evaluation of a two-hole versus a three-hole single slide test.
    Porschen R; Kruis W; Strohmeyer G
    Hepatogastroenterology; 1993 Apr; 40(2):191-3. PubMed ID: 8509054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting colorectal cancer with a large scale fecal occult blood testing program.
    Gregorio DI; Lolachi P; Hansen H
    Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.